Literature DB >> 31219579

A novel histone H4 variant H4G regulates rDNA transcription in breast cancer.

Mengping Long1, Xulun Sun1, Wenjin Shi1, An Yanru1, Sophia T C Leung1, Dongbo Ding1, Manjinder S Cheema2, Nicol MacPherson3, Christopher J Nelson2, Juan Ausio2, Yan Yan1, Toyotaka Ishibashi1.   

Abstract

Histone variants, present in various cell types and tissues, are known to exhibit different functions. For example, histone H3.3 and H2A.Z are both involved in gene expression regulation, whereas H2A.X is a specific variant that responds to DNA double-strand breaks. In this study, we characterized H4G, a novel hominidae-specific histone H4 variant. We found that H4G is expressed in a variety of human cell lines and exhibit tumor-stage dependent overexpression in tissues from breast cancer patients. We found that H4G localized primarily to the nucleoli of the cell nucleus. This localization was controlled by the interaction of the alpha-helix 3 of the histone fold motif with a histone chaperone, nucleophosmin 1. In addition, we found that modulating H4G expression affects rRNA expression levels, protein synthesis rates and cell-cycle progression. Our data suggest that H4G expression alters nucleolar chromatin in a way that enhances rDNA transcription in breast cancer tissues.
© The Author(s) 2019. Published by Oxford University Press on behalf of Nucleic Acids Research.

Entities:  

Year:  2019        PMID: 31219579     DOI: 10.1093/nar/gkz547

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  16 in total

Review 1.  The roles of histone variants in fine-tuning chromatin organization and function.

Authors:  Sara Martire; Laura A Banaszynski
Journal:  Nat Rev Mol Cell Biol       Date:  2020-07-14       Impact factor: 94.444

Review 2.  Histone variants: The unsung guardians of the genome.

Authors:  Ernest O N Phillips; Akash Gunjan
Journal:  DNA Repair (Amst)       Date:  2022-02-17

Review 3.  Chromatin regulation and dynamics in stem cells.

Authors:  David C Klein; Sarah J Hainer
Journal:  Curr Top Dev Biol       Date:  2019-12-30       Impact factor: 4.897

Review 4.  Histone H1 Mutations in Lymphoma: A Link(er) between Chromatin Organization, Developmental Reprogramming, and Cancer.

Authors:  Alexey A Soshnev; C David Allis; Ethel Cesarman; Ari M Melnick
Journal:  Cancer Res       Date:  2021-09-27       Impact factor: 13.312

Review 5.  Histone variant-specific post-translational modifications.

Authors:  Faith M Joseph; Nicolas L Young
Journal:  Semin Cell Dev Biol       Date:  2022-03-09       Impact factor: 7.499

6.  The Use of Mononucleosome Immunoprecipitation for Analysis of Combinatorial Histone Post-translational Modifications and Purification of Nucleosome-Interacting Proteins.

Authors:  Kashif Aziz Khan; Marlee K Ng; Peter Cheung
Journal:  Front Cell Dev Biol       Date:  2020-05-08

7.  H2A.Z acetylation by lincZNF337-AS1 via KAT5 implicated in the transcriptional misregulation in cancer signaling pathway in hepatocellular carcinoma.

Authors:  Yin Yuan; Wen Cao; Hongbing Zhou; Haixin Qian; Honggang Wang
Journal:  Cell Death Dis       Date:  2021-06-12       Impact factor: 8.469

Review 8.  Histone dynamics during DNA replication stress.

Authors:  Chia-Ling Hsu; Shin Yen Chong; Chia-Yeh Lin; Cheng-Fu Kao
Journal:  J Biomed Sci       Date:  2021-06-19       Impact factor: 8.410

Review 9.  Mass spectrometry-based characterization of histones in clinical samples: applications, progress, and challenges.

Authors:  Roberta Noberini; Giulia Robusti; Tiziana Bonaldi
Journal:  FEBS J       Date:  2021-01-23       Impact factor: 5.622

10.  H2A.Z is dispensable for both basal and activated transcription in post-mitotic mouse muscles.

Authors:  Edwige Belotti; Nicolas Lacoste; Thomas Simonet; Christophe Papin; Kiran Padmanabhan; Isabella Scionti; Yann-Gaël Gangloff; Lorrie Ramos; Defne Dalkara; Ali Hamiche; Stefan Dimitrov; Laurent Schaeffer
Journal:  Nucleic Acids Res       Date:  2020-05-21       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.